Morgan Stanley West Pharmaceutical Services Inc Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Morgan Stanley holds 1,485,097 shares of WST stock, worth $415 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,485,097

Previous 1,285,346 15.54%

Holding current value

$415 Million

Previous $288 Million 12.92%

% of portfolio

0.02%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	BUY	$190.39 - $227.7 $38 Million - $45.5 Million	199,751 Added 15.54%	1,485,097 $325 Million
Q1 2025 May 15, 2025	BUY	$199.11 - $347.87 $50.2 Million - $87.7 Million	252,175 Added 24.41%	1,285,346 $288 Million
Q4 2024 Feb 14, 2025	BUY	$285.69 - $344.0 $17.6 Million - $21.2 Million	61,686 Added 6.35%	1,033,171 $338 Million
Q3 2024 May 14, 2025	BUY	$277.16 - $333.3 $83.5 Million - $100 Million	301,449 Added 44.99%	971,485 $292 Million
Q3 2024 Nov 14, 2024	BUY	$277.16 - $333.3 $83.5 Million - $100 Million	301,449 Added 44.99%	971,485 $292 Million
Q2 2024 May 14, 2025	SELL	$314.68 - $395.94 $114 Million - $144 Million	-363,135 Reduced 35.15%	670,036 $221 Million
Q2 2024 Oct 17, 2024	BUY	$314.68 - $395.94 $993,444 - $1.25 Million	3,157 Added 0.47%	670,036 $221 Million
Q2 2024 Aug 14, 2024	BUY	$314.68 - $395.94 $993,444 - $1.25 Million	3,157 Added 0.47%	670,036 $221 Million
Q1 2024 Oct 17, 2024	SELL	$338.27 - $413.0 $1.07 Million - $1.3 Million	-3,157 Reduced 0.47%	666,879 $264 Million
Q1 2024 Aug 16, 2024	SELL	$338.27 - $413.0 $121 Million - $147 Million	-356,973 Reduced 34.87%	666,879 $264 Million
Q1 2024 May 15, 2024	SELL	$338.27 - $413.0 $121 Million - $147 Million	-356,973 Reduced 34.87%	666,879 $264 Million
Q4 2023 Aug 16, 2024	BUY	$318.29 - $392.21 $113 Million - $139 Million	353,816 Added 52.81%	1,023,852 $361 Million
Q4 2023 Feb 13, 2024	BUY	$318.29 - $392.21 $87.1 Million - $107 Million	273,546 Added 36.46%	1,023,852 $361 Million
Q3 2023 Nov 15, 2023	BUY	$354.9 - $412.41 $21.6 Million - $25.1 Million	60,927 Added 8.84%	750,306 $282 Million
Q2 2023 Aug 14, 2023	SELL	$334.63 - $382.47 $8.55 Million - $9.78 Million	-25,558 Reduced 3.57%	689,379 $264 Million
Q1 2023 May 15, 2023	SELL	$232.5 - $346.47 $8.46 Million - $12.6 Million	-36,405 Reduced 4.85%	714,937 $248 Million
Q4 2022 Feb 14, 2023	BUY	$209.34 - $261.61 $26 Million - $32.4 Million	123,992 Added 19.76%	751,342 $177 Million
Q3 2022 Nov 14, 2022	SELL	$246.08 - $343.65 $3.27 Million - $4.57 Million	-13,301 Reduced 2.08%	627,350 $154 Million
Q2 2022 Oct 27, 2022	BUY	$280.61 - $420.45 $72.6 Million - $109 Million	258,710 Added 67.74%	640,651 $194 Million
Q2 2022 Aug 15, 2022	BUY	$280.61 - $420.45 $72.6 Million - $109 Million	258,710 Added 67.74%	640,651 $194 Million
Q1 2022 Oct 27, 2022	SELL	$357.49 - $445.92 $92.5 Million - $115 Million	-258,710 Reduced 40.38%	381,941 $157 Million
Q1 2022 May 13, 2022	SELL	$357.49 - $445.92 $53.2 Million - $66.4 Million	-148,818 Reduced 28.04%	381,941 $157 Million
Q4 2021 Feb 14, 2022	BUY	$402.25 - $471.34 $63 Million - $73.8 Million	156,656 Added 41.88%	530,759 $249 Million
Q3 2021 Nov 15, 2021	BUY	$363.01 - $468.47 $136 Million - $175 Million	374,103 New	374,103 $159 Million

Others Institutions Holding WST

# of Institutions

830

Shares Held

68.6M

Call Options Held

344K

Put Options Held

144K

View Full List

About WEST PHARMACEUTICAL SERVICES INC

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $20.7B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

More about WST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account